Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1974 1
1975 1
1979 2
1981 1
1982 3
1983 2
1984 8
1985 9
1986 8
1987 10
1988 14
1989 10
1990 5
1991 10
1992 6
1993 10
1994 14
1995 10
1996 16
1997 15
1998 19
1999 12
2000 14
2001 18
2002 16
2003 22
2004 9
2005 19
2006 17
2007 14
2008 15
2009 22
2010 18
2011 15
2012 18
2013 18
2014 12
2015 14
2016 19
2017 23
2018 22
2019 24
2020 32
2021 22
2022 18
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

581 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Lupus anticoagulant disorder"
Page 1
Antiphospholipid syndrome.
Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, Salmon JE, Shoenfeld Y, Shovman O, Hunt BJ. Schreiber K, et al. Nat Rev Dis Primers. 2018 Jan 11;4:17103. doi: 10.1038/nrdp.2017.103. Nat Rev Dis Primers. 2018. PMID: 29321641 Review.
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and anti-beta2-glycoprotein 1 antibodies. APS can present with a variety of clini …
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies, such as lup …
Diagnosis and management of the antiphospholipid syndrome.
Chaturvedi S, McCrae KR. Chaturvedi S, et al. Blood Rev. 2017 Nov;31(6):406-417. doi: 10.1016/j.blre.2017.07.006. Epub 2017 Jul 30. Blood Rev. 2017. PMID: 28784423 Free PMC article. Review.
Laboratory diagnosis of APLA depends upon the detection of a lupus anticoagulant, which prolongs phospholipid-dependent anticoagulation tests, and/or anticardiolipin (aCL) and anti-beta2-glycoprotein-1 (beta2GPI) antibodies. ...There is a high rate of recurrent thro …
Laboratory diagnosis of APLA depends upon the detection of a lupus anticoagulant, which prolongs phospholipid-dependent antico …
Laboratory Diagnostics in Thrombophilia.
Linnemann B, Hart C. Linnemann B, et al. Hamostaseologie. 2019 Feb;39(1):49-61. doi: 10.1055/s-0039-1677840. Epub 2019 Jan 31. Hamostaseologie. 2019. PMID: 30703819 Review.
A thrombophilic disorder is a hereditary or acquired condition that increases the risk of thrombosis. ...Immunologic antigen assays and chromogenic or clot-based activity assays are used to identify deficiencies in the natural coagulation inhibitors antithrombin, pr …
A thrombophilic disorder is a hereditary or acquired condition that increases the risk of thrombosis. ...Immunologic antigen assays a …
Management of antiphospholipid syndrome.
Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Uthman I, et al. Ann Rheum Dis. 2019 Feb;78(2):155-161. doi: 10.1136/annrheumdis-2018-213846. Epub 2018 Oct 3. Ann Rheum Dis. 2019. PMID: 30282668 Review.
Antiphospholipid syndrome, also known as 'Hughes Syndrome', is an autoimmune disease characterised by a set of clinical manifestations, almost all of which are direct or indirect sequelae of a hypercoagulable state involving the venous, and to a lesser extent the ar …
Antiphospholipid syndrome, also known as 'Hughes Syndrome', is an autoimmune disease characterised by a set of clinical manife …
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
van Dijk MM, Vissenberg R, Fliers E, van der Post JAM, van der Hoorn MP, de Weerd S, Kuchenbecker WK, Hoek A, Sikkema JM, Verhoeve HR, Broeze KA, de Koning CH, Verpoest W, Christiansen OB, Koks C, de Bruin JP, Papatsonis DNM, Torrance H, van Wely M, Bisschop PH, Goddijn M. van Dijk MM, et al. Lancet Diabetes Endocrinol. 2022 May;10(5):322-329. doi: 10.1016/S2213-8587(22)00045-6. Epub 2022 Mar 14. Lancet Diabetes Endocrinol. 2022. PMID: 35298917 Clinical Trial.
Women (18-42 years) who were TPO-Ab positive, had two or more pregnancy losses, and had a thyroid stimulating hormone (TSH) concentration within the institutional reference range were eligible for inclusion. Women were excluded if they had antiphospholipid syndrome (lupus …
Women (18-42 years) who were TPO-Ab positive, had two or more pregnancy losses, and had a thyroid stimulating hormone (TSH) concentration wi …
Systemic lupus erythematosus and menopause.
Gompel A. Gompel A. Climacteric. 2020 Apr;23(2):109-115. doi: 10.1080/13697137.2019.1679113. Epub 2019 Oct 28. Climacteric. 2020. PMID: 31657240 Review.
However, the severity of the disease may vary and some women with lupus could benefit from a menopausal hormone therapy (MHT). As a consequence, management of menopause symptoms needs to evaluate carefully the condition of the patient, her lupus history and c …
However, the severity of the disease may vary and some women with lupus could benefit from a menopausal hormone therapy (MHT). …
Combined oral contraceptives in women with systemic lupus erythematosus.
Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP; OC-SELENA Trial. Petri M, et al. N Engl J Med. 2005 Dec 15;353(24):2550-8. doi: 10.1056/NEJMoa051135. N Engl J Med. 2005. PMID: 16354891 Free article. Clinical Trial.
In this double-blind, randomized, noninferiority trial, we prospectively evaluated the effect of oral contraceptives on lupus activity in premenopausal women with systemic lupus erythematosus. ...Subjects were excluded if they had moderate or high leve …
In this double-blind, randomized, noninferiority trial, we prospectively evaluated the effect of oral contraceptives on lup …
Antiphospholipid syndrome.
George D, Erkan D. George D, et al. Prog Cardiovasc Dis. 2009 Sep-Oct;52(2):115-25. doi: 10.1016/j.pcad.2009.06.005. Prog Cardiovasc Dis. 2009. PMID: 19732604 Free article. Review.
The antiphospholipid syndrome (APS) is an autoimmune systemic disease that is diagnosed when there is vascular thrombosis and/or pregnancy morbidity occurring with persistently positive antiphospholipid antibodies (aPL) (lupus anticoagulant test, anticardioli …
The antiphospholipid syndrome (APS) is an autoimmune systemic disease that is diagnosed when there is vascular thrombosis and/or preg …
Immunotherapy in antiphospholipid syndrome.
Lopez-Pedrera Ch, Aguirre MA, Ruiz-Limon P, Pérez-Sánchez C, Jimenez-Gomez Y, Barbarroja N, Cuadrado MJ. Lopez-Pedrera Ch, et al. Int Immunopharmacol. 2015 Aug;27(2):200-8. doi: 10.1016/j.intimp.2015.06.006. Epub 2015 Jun 15. Int Immunopharmacol. 2015. PMID: 26086363 Review.
Antiphospholipid syndrome (APS) is a disorder characterized by the association of arterial or venous thrombosis and/or pregnancy morbidity with the presence of antiphospholipid antibodies (anticardiolipin antibodies, lupus anticoagulant antibodies, and/or ant …
Antiphospholipid syndrome (APS) is a disorder characterized by the association of arterial or venous thrombosis and/or pregnancy morb …
Management of maternal antiphospholipid syndrome.
Fernandes MA, Gerardi MC, Andreoli L, Tincani A. Fernandes MA, et al. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):149-156. Epub 2019 Jun 28. Clin Exp Rheumatol. 2020. PMID: 31287415 Review.
Antiphospholipid syndrome (APS) is a systemic autoimmune disease which manifests as thrombotic and/or obstetric adverse events, mediated by persistent circulating antiphospholipid antibodies (aPL) detected by means of three tests: lupus anticoagulant, anticar …
Antiphospholipid syndrome (APS) is a systemic autoimmune disease which manifests as thrombotic and/or obstetric adverse events, media …
581 results